In designing the study questions, the EPC consulted several Key Informants who represent the end-users of research. The EPC sought the Key Informant input on the priority areas for research and synthesis. Key Informants are not involved in the analysis of the evidence or the writing of the report. Therefore, in the end, study questions, design, methodological approaches, and/or conclusions do not necessarily represent the views of individual Key Informants.

Key Informants must disclose any financial conflicts of interest greater than $5,000 and any other relevant business or professional conflicts of interest. Because of their role as end-users, individuals with potential conflicts may be retained. The TOO and the EPC work to balance, manage, or mitigate any conflicts of interest.

The list of Key Informants who provided input into this report follows:

• Benjamin G. Druss, M.D., M.P.H.
  Rosalynn Carter Chair in Mental Health
  Department of Health Policy and Management
  Atlanta, GA
• Brian Jost
  NAMI Minnesota
  St. Paul, MN
• Amy M. Kilbourne, Ph.D., M.P.H.^*
  Director, VA Quality Enhancement Research Initiative (QUERI)
  Professor of Psychiatry, University of Michigan Medical School
  Ann Arbor, MI
• Elinore F. McCance-Katz, M.D.
  Chief Medical Officer
  Substance Abuse and Mental Health Services
  Washington, DC
• Susan Carr Sonne, Pharm.D., B.C.P.P.
  MUSC/Institute of Psychiatry
  Charleston, SC
• Lauren M. Weinstock, Ph.D.^*
  Associate Professor
  Alpert Medical School of Brown University
  Providence, RI